Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Items 501–600 of 783
Prostaglandin I 2 suppresses the development of diet‐induced nonalcoholic steatohepatitis in mice
Kumei, S., Yuhki, K., Kojima, F., Kashiwagi, H., Imamichi, Y., Okumura, T., Narumiya, S., & Ushikubi, F. (2017) · The FASEB Journal · doi:10.1096/fj.201700590r · Cited by 17
Self-citationInhibitory Effects of Beraprost on Platelet Aggregation
Yang, L., Yatomi, Y., Satoh, K., & Ozaki, Y. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(98)00187-x · Cited by 17
Komoike, Y., Nakashima, M., Nakagiri, A., & Takeuchi, K. (2003) · Digestion · doi:10.1159/000072057 · Cited by 16
Turner, E. C., & Kinsella, B. T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.030 · Cited by 17
Kashiwagi, H., Yuhki, K., Imamichi, Y., Kojima, F., Kumei, S., Tasaki, Y., Narumiya, S., & Ushikubi, F. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1688906 · Cited by 16
Self-citationProfiling of prostanoids in zebrafish embryonic development
Yeh, H.-C., & Wang, L. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.08.001 · Cited by 16
Sugimoto, M., Arai, I., Futaki, N., Hashimoto, Y., Honma, Y., & Nakaike, S. (2005) · Experimental Dermatology · doi:10.1111/j.1600-0625.2005.00375.x · Cited by 16
“Moreover, PGE2 and PGI2 play major roles in edema formation (30) and inflammation-related pain (31,32).”
BackgroundOgino, K., Hatanaka, K., Kawamura, M., Ohno, T., & Harada, Y. (2000) · Pharmacology · doi:10.1159/000028408 · Cited by 16
Stitham, J., Arehart, E. J., Gleim, S., Douville, K. L., MacKenzie, T. A., & Hwa, J. (2007) · Gene · doi:10.1016/j.gene.2007.03.016 · Cited by 16
“prostacyclin receptor (IP) knock-out mice have revealed increased propensities towards thrombosis (Murata et al., 1997), intimal hyperplasia and restenosis (Cheng et al.”
BackgroundIwasaki, K., Noguchi, K., & Ishikawa, I. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02228.x · Cited by 19
Pain Management - Practices, Novel Therapies and Bioactives
Waisundara, V. Y., Banjari, I., & Balkić, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87267 · Cited by 17
Oba, K., Hosono, K., Amano, H., Okizaki, S.-I., Ito, Y., Shichiri, M., & Majima, M. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.022 · Cited by 15
Schuh, C., Brenneis, C., Zhang, D. D., Angioni, C., Schreiber, Y., Ferreiros-Bouzas, N., Pierre, S. C., Henke, M., Linke, B., Nüsing, R. M., et al. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182a76f74 · Cited by 16
Hirata, Y., Shimabukuro, M., Uematsu, E., Soeki, T., Yamada, H., Sakai, Y., Nakayama, M., Matsumoto, K., Igarashi, T., & Sata, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.038 · Cited by 15
“Previous studies demonstrated the favorable effects of prostacyclin in maintaining homeostasis of cardiovascular system, including an antithrombotic effect (Murata et al., 1997), suppression of cardiac hypertrophy (Hara et al.”
BackgroundLyu, S. A., Lee, S. Y., Lee, S. J., Son, S. W., Kim, M. O., Kim, G., Kim, Y. H., Yoon, H., Kim, H., Park, D. I., et al. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.002 · Cited by 15
In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics
Mousa, S. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-803-4_2 · Cited by 15
“Receptor (PGI2R) Mice are viable, fertile, and normotensive, with increased susceptibility to thrombosis and reduced inflammatory and pain responses (246).”
BackgroundThe Remarkable Mechanism of Prostaglandin E2 on Synaptic Plasticity
Akaneya, Y. (2007) · Gene Regulation and Systems Biology · doi:10.1177/117762500700100009 · Cited by 15
“However, a KO study on the receptors involved revealed that this type of pain may require receptors for PGI2 rather than PGE2 (Murata et al. 1997).”
BackgroundCOX‐1, COX‐2 and articular joint disease: A role for chondroprotective agents
Colville‐Nash, P., & Willoughby, D. A. (2002) · Biorheology · doi:10.1177/0006355x2002039001002031 · Cited by 15
“Similarly PGI2 plays a prominent role in the development of acute inflammatory reactions [46].”
Ricciotti, E., Castro, C., Tang, S. Y., Briggs, W. T. E., West, J. A., Malik, D. M., Rhoades, S. D., Meng, H., Li, X., Lahens, N. F., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033540 · Cited by 15
O'Meara, S. J., & Kinsella, B. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705956 · Cited by 15
“Prostacyclin plays a key role in vascular haemostasis (Vane & Botting, 1995), but is also a potent pain and pro-inflammatory mediator (Murata et al., 1997); it confers a cytoprotective effect against tissue injury during acute myocardial ischaemia (Sakai et al., 1990; Xiao et al., 2001) and…”
BackgroundFong, C. W., Bahia, D. S., Rees, S., & Milligan, G. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.249 · Cited by 15
“Indeed, the recent production of mice lacking the IP prostanoid receptor (Murata et al., 1997) has confirmed its central role in the regulation of platelet aggregation and vasodilation and hinted at contributions to the regulation of inflammation and pain perception.”
BackgroundBelton, O., & Fitzgerald, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00305-x · Cited by 15
“There have been reports that disruption of the IP receptor aggravates atherosclerosis in low-density lipoprotein receptor (LDLR) knockout mice (23); furthermore, it has been suggested that deletion of the IP receptor results in increased sensitivity to thrombotic stimuli (24).”
BackgroundLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch19 · Cited by 21
Kurth, T., Hennekens, C. H., Buring, J. E., & Gaziano, J. M. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0009-0 · Cited by 14
Hattori, Y., Ohno, T., Ae, T., Saeki, T., Arai, K., Mizuguchi, S., Saigenji, K., & Majima, M. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00292.2007 · Cited by 14
“The activity of EP2/4 agonists may be not CGRP-dependent, as mentioned above.”
BackgroundEikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2014) · Cited by 15
Wu, R., Duchemin, S., Laplante, M., de Champlain, J., & Girouard, H. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.137 · Cited by 14
Knockout Mouse Models in Pain Research
Dierich, A., & Kieffer, B. L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:167 · Cited by 21
Blitek, A., Szymańska, M., Morawska-Pucinska, E., Małysz‐Cymborska, I., & Andronowska, A. (2015) · Theriogenology · doi:10.1016/j.theriogenology.2015.05.034 · Cited by 14
“Moreover, both female andmale homozygousmutantmice null for Ptgir are fertile [26], indicating that this gene is not critical for implantation in this species.”
BackgroundBill, A., Rosethorne, E. M., Kent, T. C., Fawcett, L., Burchell, L., van Diepen, M. T., Marelli, A., Batalov, S., Miraglia, L. J., Orth, A. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097973 · Cited by 14
“Recent studies have revealed a cardioprotective role of the IP receptor and hIP receptor dysfunction has been implicated in numerous cardiovascular abnormalities, including myocardial infarction, hypertension, thrombosis and atherosclerosis [4–9].”
BackgroundInhibition of Platelet Function by the Endothelium
Rex, S., & Freedman, J. E. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50775-8 · Cited by 14
Nieuwenhuys, C. M. A., Feijge, M. A. H., Offermans, R. F. G., Kester, A. D. M., Hornstra, G., & Heemskerk, J. W. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00503-7 · Cited by 15
Signaling Receptors on Platelets and Megakaryocytes
Woulfe, D. S., Yang, J., Prévost, N., O'Brien, P. J., Fortna, R. R., Tognolini, M., Jiang, H., Wu, J., & Brass, L. F. (2004) · Humana Press eBooks · doi:10.1385/1-59259-783-1:003 · Cited by 14
Radiation myelopathy: a radiobiological review
Shirazi, A., Mahdavi, S. R., & Trott, K. R. (2004) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/s1507-1367(04)71019-6 · Cited by 14
Klein, T., Klaus, G., & Kömhoff, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/654151 · Cited by 13
“Considering the multiple defects in renal development in PGIS-ko mice, including increased interstitial fibrosis [3], leads to speculation that prostacyclin plays an important role in the prevention of fibrosis and that this process may be modulated via PPAR-𝛽/𝛿 (given the normal renal phenotype in IP-ko-mice [9]).”
BackgroundInfluentialProinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo
Hayashi, I., Ishihara, K., Kumagai, Y., & Majima, M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704208 · Cited by 13
“Another nonpeptide agonist, L-162,313, which bound to angiotensin AT1 receptor stably expressed in COS-7 cells, has also been shown to have 50% of the maximal angiotensin II response to stimulate inositol phosphate accumulation (Perlman et al., 1995).”
BackgroundNAGAMATSU, Y., Tsujioka, Y., Hashimoto, M., Giddings, J. C., & Yamamoto, J. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00189.x · Cited by 13
Mizuguchi, S., Ohno, T., Hattori, Y., Ae, T., Minamino, T., Satoh, T., Arai, K., Saeki, T., Hayashi, I., Sugimoto, Y., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00524.2009 · Cited by 12
Self-citationBorgdorff, P., Handoko, M. L., Wong, Y. Y., & Tangelder, G. J. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010198 · Cited by 13
“Our finding that COX-2 inhibition did not by itself elicit platelet aggregation complies with the absence of spontaneous thrombosis in mice lacking receptors for PGI2 [44], and the observation of Arehart et al.”
BackgroundDonnellan, P. D., & Kinsella, B. T. (2009) · Journal of Molecular Signaling · doi:10.1186/1750-2187-4-7 · Cited by 12
Kashiwagi, H., Yuhki, K., Kojima, F., Kumei, S., Takahata, O., Sakai, Y., Narumiya, S., & Ushikubi, F. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.222612 · Cited by 12
Self-citationCigarette Smoke Extract Inhibits Platelet Aggregation by Suppressing Cyclooxygenase Activity
Kashiwagi, H., Yuhki, K., Imamichi, Y., Kojima, F., Kumei, S., Higashi, T., Horinouchi, T., Miwa, S., Narumiya, S., & Ushikubi, F. (2017) · TH Open · doi:10.1055/s-0037-1607979 · Cited by 13
Self-citationGroßer, T. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181b04d1f · Cited by 12
Activation of G i -coupled receptors releases a tonic state of inhibited platelet aggregation
Maayani, S., Schwarz, T. E., Martinez, R., & Tagliente, T. M. (2001) · Platelets · doi:10.1080/09537100020032055 · Cited by 12
“production, may be important in maintaining the tonic state of deaggregation.(27) Preliminary data from our laboratory shows that agents known to elevate cAMP (i.”
BackgroundRoizen, J. D., Asada, M., Tong, M., Tai, H., & Muglia, L. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54064-7 · Cited by 11
Chagas, L. R., Silva, J. A., Pires, J. M. M. V., & Costa, M. S. (2014) · Lasers in Medical Science · doi:10.1007/s10103-014-1622-4 · Cited by 11
Donnellan, P. D., Kimbembe, C. C., Reid, H. M., & Kinsella, B. T. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.01.003 · Cited by 11
“The prostanoid prostacyclin, or prostaglandin I 2 , mainly produced by the vascular endothelium [11], is a potent proinflammatory mediator [12, 13] and plays a central role in haemostasis, inhibiting platelet aggregation and inducing vasodilation [14, 15].”
BackgroundAbramovitz, M., & Metters, K. M. (1998) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61087-8 · Cited by 11
Pearson, J. T., Shirai, M., Yokoyama, C., Tsuchimochi, H., Schwenke, D. O., Shimouchi, A., Kangawa, K., & Tanabe, T. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0175-1 · Cited by 11
“Therefore, we also confirm that endogenous PGI2 is not essential for normal cardiovascular and ventilatory functions in normoxia [23, 32, 33].”
BackgroundPotentiation of Ibudilast Inhibition of Platelet Aggregation in the Presence of Endothelial Cells
Rile, G., Yatomi, Y., Qi, R., Satoh, K., & Ozaki, Y. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00258-4 · Cited by 11
Induction of prostaglandin I2 receptor by tumor necrosis factor α in osteoblastic MC3T3-E1 cells
Wang, J., Yamamoto, K., Sugimoto, Y., Ichikawa, A., & Yamamoto, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00139-0 · Cited by 11
Self-citationA Novel 7-Transmembrane Receptor Expressed in Nerve Growth Factor-Dependent Sensory Neurons
Friedel, R. H., Stubbusch, J., Barde, Y., & Schnürch, H. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0912 · Cited by 11
Role of Clinical Pharmacology in the Development of Antiplatelet Drugs
Patrono, C. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.10.012 · Cited by 11
Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humans
Gholamreza-Fahimi, E., Bisha, M., Hahn, J., Straßen, U., Krybus, M., Khosravani, F., Hoffmann, T. K., Hohlfeld, T., Greve, J., Baş, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109797 · Cited by 10
“Unfortunately, the effect of bradykinin alone on extravasation in PGI2-receptor (IP) deficient mice was not evaluated, although this study nicely demonstrated a strong inhibition of dermal extravasation induced by the combination of bradykinin/PGI2 [31].”
BackgroundA biologically active lipid, thromboxane, as a regulator of angiogenesis and lymphangiogenesis
Majima, M., Hosono, K., Ito, Y., Amano, H., Nagashima, Y., Matsuda, Y., Watanabe, S.-I., & NISHIMURA, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114831 · Cited by 10
Patrono, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00050-3 · Cited by 11
Cyclooxygenase-2 and Skin Carcinogenesis
F�rstenberger, G., Marks, F., & M�ller-Decker, K. (2003) · KARGER eBooks · doi:10.1159/000071367 · Cited by 12
Prostacyclin Regulates Bone Growth via the Epac/Rap1 Pathway
Hutchison, M. R., & White, P. C. (2014) · Endocrinology · doi:10.1210/en.2014-1348 · Cited by 10
“Mice with a global deletion of the PGI2 receptor were also reported to be normally grown (75).”
BackgroundSugimoto, M., Arai, I., Futaki, N., Hashimoto, Y., Sakurai, T., Honma, Y., & Nakaike, S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.080 · Cited by 10
Wang, M., Cooper, P. R., Jiang, M., Zhao, H., Hui, Y., Yao, Y., Tate, J. C., Damera, G., Lawson, J. A., Jester, W. F., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166678 · Cited by 10
“Ironically, this tends to undermine the original intent of developing mPGES-1 inhibitors as PGI2 , such as PGE2, that can mediate pain and inflammation (Murata et al., 1997; Honda et al., 2006).”
BackgroundCharacterization of the PGI2/IP system in cultured rat mesangial cells
Nasrallah, R., Landry, A., Scholey, J. W., & Hébert, R. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.004 · Cited by 10
Potential Cardiovascular Effects of COX-2 Selective Nonsteroidal Antiinflammatory Drugs
Fowles, R. E. (2003) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v17n02_03 · Cited by 10
Pulmonary Arterial Hypertension: Classification and Therapy With a Focus on Prostaglandin Analogs
Papierniak, E. S., Lowenthal, D. T., & Mubarak, K. K. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31820e828c · Cited by 9
“Like with other prostaglandins, PGI2 is a mediator of inflammation and nociception.(72,73) The IP receptor primarily couples with the Gs protein and increases the intracellular concentration of cAMP in much the same way as EP2 receptors.”
Biased signaling in platelet G-protein coupled receptors
Thibeault, P. E., & Ramachandran, R. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0149 · Cited by 9
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs
Capone, M. L., Tacconelli, S., Francesco, L. D., Petrelli, M., & Patrignani, P. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.1.29 · Cited by 10
“Evidences from rodent models show that prostacyclin is a constrain to hypertension, cardiac hypertrophy and severe cardiac fibrosis [30-33] .”
BackgroundInflammatory Hyperalgesia: The Role of the Prostaglandin System in the Spinal Cord
Fujikawa, M., Ibuki, T., Matsumura, K., & Sawa, T. (2012) · Advances in Neuroimmune Biology · doi:10.3233/nib-2012-012041 · Cited by 9
“) writhing ↓ [70] PGI2 (s.”
Brescia, M., Rokosz, L. L., Cole, A. G., Stauffer, T. M., Lehrach, J. M., Auld, D. S., Henderson, I. M., & Webb, M. L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.025 · Cited by 9
Noguchi, K., Iwasaki, K., Endo, H., Kondo, H., Shitashige, M., & Ishikawa, I. (2000) · Oral Microbiology and Immunology · doi:10.1034/j.1399-302x.2000.150505.x · Cited by 10
Zhao, M., Li, Z., Peng, L., Tang, Y., Wang, C., Zhang, Z., & Peng, S. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.023 · Cited by 9
A Systems Approach to the Platelet Signaling Network and the Hemostatic Response to Injury
Brass, L. F., Ma, P., Tomaiuolo, M., Diamond, S. L., & Stalker, T. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_27 · Cited by 9
Lipid-Mediator-Deficient Mice in Models of Inflammation
Funk, C. D. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-253-1_5 · Cited by 9
Kakizuka, S., Takeda, T., Komiya, Y., Koba, A., Uchi, H., Yamamoto, M., Furue, M., Ishii, Y., & Yamada, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00235 · Cited by 9
Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I2 Receptor
Li, J., Guan, Y., Xu, Y., Cao, Y., Xie, Q., Harris, R. C., Breyer, M. D., Lü, L., & Hao, C. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000286 · Cited by 8
“52 Previous studies showed that PTGIR is primarily expressed in vascular tissue.”
BackgroundPagani-Estévez, G. L., Swetz, K. M., McGoon, M. D., Frantz, R. P., Tointon, S. K., Karnyski, A. M., Durst, L. A., & Watson, J. C. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-674oc · Cited by 8
Vinokurova, M., Pires, M. E. L., Cypaite, N., Shala, F., Armstrong, P. C. J., Ahmetaj‐Shala, B., Elghazouli, Y., Nüsing, R. M., Liu, B., Zhou, Y., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318923 · Cited by 9
Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior
Vollert, C. T., Ohia-Nwoko, O., Akasaka, H., Berridge, C., Ruan, K.-H., & Eriksen, J. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.012 · Cited by 9
Bisha, M., Dao, V. T.-V., Gholamreza-Fahimi, E., Vogt, M., van Zandvoort, M. A. M. J., Weber, S., Baş, M., Khosravani, F., Kojda, G., & Suvorava, T. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14166 · Cited by 8
“…inhibition of dermal extravasation induced by the combination of bradykinin/PGI2 in PGI2-receptor (IP receptor) deficient mice as compared with transgene negative mice, but a possible influence of IP receptor deficiency on the response to bradykinin alone was not investigated (Murata et al., 1997).”
BackgroundSeeger, D. R., Golovko, S. A., & Golovko, M. Y. (2019) · Lipids · doi:10.1002/lipd.12205 · Cited by 8
Ayoub, S. S., & Botting, R. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-59745-364-6_18 · Cited by 7
Yarboro, M. T., Boatwright, N., Sekulich, D. C., Hooper, C. W., Wong, T., Poole, S. D., Berger, C. D., Brown, A. J., Jetter, C. S., Sucre, J. M. S., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00294.2023 · Cited by 7
Batool, Z., Kamal, M. A., & Shen, B. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101129 · Cited by 7
Polyunsaturated Fatty Acids and Inflammatory Diseases
Ferrante, A., & Hii, C. S. T. (2011) · InTech eBooks · doi:10.5772/25972 · Cited by 7
Libri, V., Gibbs, J. S. R., Pinato, D. J., Iddamalgoda, T., Khengar, R. H., Gin‐Sing, W., Huson, L., & Anand, P. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet308 · Cited by 7
Analgesic Effects of 1st Generation Anti-histamines in Mice
Takahashi, M., Shima, K., Tsuchiya, M., Hagiwara, Y., Mizoguchi, H., Sakurada, S., Sugawara, S., Fujita, T., Tadano, T., Watanabe, M., et al. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00755 · Cited by 7
Krybus, M., Sieradzki, M., Gholamreza-Fahimi, E., Metry, S., Nüsing, R. M., Geißlinger, G., Steiner, I., Daldrup, T., Lehr, M., & Kojda, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112786 · Cited by 7
Keating, G. L., Turner, E. C., & Kinsella, B. T. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.010 · Cited by 7
“In keeping with the diverse actions of prostacyclin, the hIP is widely expressed throughout the vasculature, including in platelets/megakaryocytes, macrophages, vascular endothelial and smooth muscle cells, as well as in the heart, lung, kidney and sensory neurons of the dorsal root ganglion [1, 9, 10].”
BackgroundHonma, Y., Arai, I., Futaki, N., Hashimoto, Y., Sugimoto, M., Sakurai, T., & Nakaike, S. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07882.x · Cited by 7
Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1
Turner, E. C., & Kinsella, B. T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029314 · Cited by 7
RetractedCyclooxygenase‐2 and atherosclerosis: friend or foe?
Massy, Z. A., & Swan, S. K. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.12.2286 · Cited by 7
Eivers, S. B., & Kinsella, B. T. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.06.011 · Cited by 7
“For example, IP mice display increased incidence of occlusive thrombi and enhanced predisposition towards atherosclerosis and restenosis compared to wild type mice [10, 11].”
BackgroundProstaglandins and Other Lipid Mediators in Reproductive Medicine
Funk, C. D., Song, W., & FitzGerald, G. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00006-1 · Cited by 7
Absence of prostacyclin greatly relieves cyclophosphamide‐induced cystitis and bladder pain in mice
Ochiai, T., Sasaki, Y., Yokoyama, C., Kuwata, H., & Hara, S. (2021) · The FASEB Journal · doi:10.1096/fj.202101025r · Cited by 8
Nakashima, M., Aoi, M., Aihara, E., & Takeuchi, K. (2004) · Digestion · doi:10.1159/000080077 · Cited by 7
Hishinuma, T., Nakamura, H. K., Sawai, T., Mitomo, T., Inoue, H., Matsumoto, F., & Mizugaki, M. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0293 · Cited by 7
Obata, T. (2002) · Analytica Chimica Acta · doi:10.1016/s0003-2670(02)00465-8 · Cited by 7
Prostanoid receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
BREYER, R. M., Clapp, L. H., Coleman, R. A., Giembycz, M. A., Heinemann, Á., Hills, R., Jones, R. L., Narumiya, S., Norel, X., Pettipher, R., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f58/2019.5 · Cited by 6
Self-citationLantana canescens (Kunth) inhibits inflammatory and hyperalgesic responses in murine models
Lencina, J. D. S., Moslaves, I. S. B., Muller, J. D. A. I., Carvalho, R., Amianti, C., Bonfim, I., Alves, F. M., Carollo, C. A., Portugal, L. C., Júnior, A. A. D. S., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114461 · Cited by 6
Analgesic and CNS Depressant Effect of the Crude Ethanolic Extract of the Operculina turpethum
Islam, M. N. (2015) · Biosensors Journal · doi:10.4172/2090-4967.1000132 · Cited by 6
Nagy, Z., & Senis, Y. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00015-1 · Cited by 8
Prostacyclin Synthase as an Ambivalent Regulator of Inflammatory Reactions
Ochiai, T., Honsawa, T., Sasaki, Y., & Hara, S. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00370 · Cited by 7
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.